Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease

J Nucl Med. 1995 Nov;36(11):1945-52.

Abstract

The aim of this study was to assess whether nitrate administration improves the imaging capabilities of 99mTc-MIBI tomography in detecting viable myocardium in coronary artery disease (CAD).

Methods: Thirty-one patients with angiographically proven CAD and chronic LV dysfunction (ejection fraction 39% +/- 9%) underwent two 99mTc-MIBI studies on separate days: one under rest conditions and the other after nitroglycerine (0.005 mg/kg per os) administration. Within 1 wk, all patients also underwent rest-redistribution 201Tl imaging. Eight patients were also studied by echocardiography before and 5 +/- 3 mo after coronary revascularization.

Results: On resting 99mTc-MIBI images, 302 segments had normal uptake, 183 segments had moderately reduced uptake and 197 had severely reduced uptake. Of the segments with severely reduced uptake, 54 (27%) had increased uptake after nitroglycerine and were viable on 201Tl images. Of the 143 (73%) segments with severely reduced 99mTc-MIBI uptake and no change after nitroglycerine, 81% were nonviable on 201Tl images. In the eight patients studied before and after revascularization, 87% of segments with reversible 99mTc-MIBI defects and abnormal LV function demonstrated functional recovery after revascularization, whereas 89% of segments with irreversible 99mTc-MIBI defects did not.

Conclusion: In patients with chronic ischemic LV dysfunction, nitrate administration improved the detection of severely hypoperfused but still viable myocardium on 99mTc-MIBI images.

Publication types

  • Comparative Study

MeSH terms

  • Coronary Circulation / drug effects
  • Coronary Disease / diagnostic imaging*
  • Coronary Disease / therapy
  • Echocardiography
  • Female
  • Heart / diagnostic imaging*
  • Humans
  • Male
  • Middle Aged
  • Myocardial Revascularization
  • Nitroglycerin*
  • Technetium Tc 99m Sestamibi*
  • Thallium Radioisotopes
  • Time Factors
  • Tomography, Emission-Computed, Single-Photon
  • Vasodilator Agents*
  • Ventricular Dysfunction, Left / diagnostic imaging

Substances

  • Thallium Radioisotopes
  • Vasodilator Agents
  • Technetium Tc 99m Sestamibi
  • Nitroglycerin